• Join
  • Login
  • Contact

Search abstracts

Predicting interactions of rifampin and antihypertensive drugs using BDDCS

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: LIU, Wei (Peking University Third Hospital, Pharmacy Department, Beijing, China)
  • Co-author(s): Tingting Yan:Pharmacy Department,Peking University Third Hospital,Beijing,China|Wei Liu:|Ken Chen:Pharmacy Department,Peking University Third Hospital,Beijing,China|Li Yang:Pharmacy Department,Peking University Third Hospital,Beijing,China|Leslie Benet:Department of Pharmacy,University of California, San Francisco,San Francisco,United States|Suodi Zhai:Pharmacy Department,Peking University Third Hospital,Beijing,China
  • Abstract:

    Lack of blood pressure control is often seen in hypertensive patients concomitantly taking antituberculosis (anti-TB) medications due to the complex drug-drug interactions (DDI) between rifampin and antihypertensive drugs. 

    Antihypertensive drugs were classified into 4 categories under BDDCS Classifications. Predictions were made under the theory


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses